Arlington Heights, Illinois Clinical Trials

A listing of Arlington Heights, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 190 clinical trials
featured
The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study for Occlusive and Re-stenotic Fem-pop Revascularization - 2 Trial: TORUS 2

The primary objective of the TORUS 2 IDE Clinical Study is to evaluate the safety and effectiveness of the TORUS Stent Graft System in the treatment of obstructive atherosclerotic lesions of the native SFA or the superficial femoral and/or proximal popliteal arteries.

AMITA Health
 (7.7 away) Contact site
  • 17 views
  • 23 Nov, 2020
  • 1 location
featured
Art Therapy Research Study.

This study is looking for people who have early stage Alzheimer’s. The study is testing the effects of art therapy on relationships.

Advocate Memory Center
 (9.9 away) Contact site
  • 0 views
  • 29 Jun, 2021
  • 1 location
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.  

primary tumor
FGFR1
malignancies
metastasis
solid tumors
Illinois Cancer Specialists
 (3.2 away) Contact site
  • 46 views
  • 14 Dec, 2020
  • +61 other locations
featured
Arise 2 - A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia

This is a randomized, placebo-controlled, double-blind, crossover study of oral BTD-001 in adults with Idiopathic Hypersomnia.  

hypersomnia
Northshore Sleep Medicine
 (6.8 away) Contact site
  • 607 views
  • 23 Nov, 2020
  • +17 other locations
featured
A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Deerbrook Medical Associates
 (8.1 away) Contact site
  • 2362 views
  • 23 Nov, 2020
  • +17 other locations
featured
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.

advanced lung cancer
refractory non-small cell lung cancer
recurrent non-small cell lung cancer
lung metastases
lung cancer
Mirati Research Site
 (3.4 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +37 other locations
featured
A Phase 2a, Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression

The main purpose of this study is to assess the efficacy and safety of daily and intermittent dosing of MK-1942 compared to placebo among participants with Treatment-Resistant Depression (TRD) on a stable course of antidepressant therapy.The dual primary hypotheses of the study are that the daily MK-1942 treatment and/or intermittent …

AMITA Health
 (8.9 away) Contact site
  • 0 views
  • 23 Mar, 2021
  • 1 location
Long Term Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This is an extension study of the Phase 3 Studies 15-AVP-786-301, 15-AVP-786-302, and 17-AVP-786-305, which also allows participants from the Phase 2 Study 12-AVR-131 to be included.

Alexian Brothers Neurosciences Institute
 (7.2 away) Contact site
  • 0 views
  • 11 Jul, 2021
  • +296 other locations
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine

The main purpose of this study is to evaluate the efficacy and safety of galcanezumab for the preventive treatment of chronic migraine in participants 12 to 17 years of age. The primary objective is to demonstrate the superiority of galcanezumab versus placebo in the reduction of monthly migraine headache days …

AMITA Health - Alexian Brothers Neurosciences Institute Clinical Research
 (7.8 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +78 other locations
Flexible-Dose Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TemPo-3)

The purpose of this study is to assess the effect of tavapadon on the change from baseline in total daily hours of "on" time without troublesome dyskinesia in L-Dopa-treated participants with Parkinson's Disease (PD) who are experiencing motor fluctuations.

dopa
amantadine
carbidopa
dyskinesia
carbidopa/levodopa
Neurosciences Research
 (7.5 away) Contact site
  • 0 views
  • 31 Jul, 2021
  • +101 other locations